Wakamoto Pharmaceutical Co.,Ltd.
JPX: 4512.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Tomoyuki Hirai
- Employees
- 403
- Headquarters
- Tokyo, Japan
- IPO year
- 2001
- Market cap
- ¥12.4B
- Website
- https://www.wakamoto-pharm.co.jp
Loading 4512…
Loading profile data…Frequently asked questions about 4512
What does Wakamoto Pharmaceutical Co.,Ltd. (4512.T) do?
Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medica...
Where does 4512.T trade?
Wakamoto Pharmaceutical Co.,Ltd. (4512.T) trades on the Tokyo Stock Exchange.
What sector is 4512.T in?
Wakamoto Pharmaceutical Co.,Ltd. (4512.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Wakamoto Pharmaceutical Co.,Ltd.?
Tomoyuki Hirai is the chief executive officer of Wakamoto Pharmaceutical Co.,Ltd. (4512.T).
Where is Wakamoto Pharmaceutical Co.,Ltd. headquartered?
Wakamoto Pharmaceutical Co.,Ltd. is headquartered in Japan.
Does 4512.T pay a dividend?
Yes — Wakamoto Pharmaceutical Co.,Ltd. (4512.T) paid a trailing twelve-month dividend of JPY 3.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4512.T go public?
Wakamoto Pharmaceutical Co.,Ltd. (4512.T) completed its initial public offering in 2001.